| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 10917753 | Radiotherapy and Oncology | 2016 | 6 Pages |
Abstract
This protocol is feasible and very well tolerated with low genitourinary morbidity, no gastrointestinal toxicity but no the same level of LDR biochemical control at 6Â years.
Keywords
DVHIMRTCTVPTVPSAHDRD90LDRAJCCSPSSTFsTRUSstandard deviationsBrachytherapyPlanning target volumeBEDClinical target volumeGastrointestinalBiologically effective doseProstate cancerGenitourinaryMonotherapyHigh dose rateLow dose rateDose–volume histogramIntensity modulated radiotherapyAmerican Joint Committee on Cancer
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
Pedro J. Prada, Juan Cardenal, Ana GarcÃa Blanco, Javier Anchuelo, MarÃa Ferri, Gema Fernández, Elisabeth Arrojo, Andrés Vázquez, Maite Pacheco, José Fernández,